Morgan Stanley raises Pharvaris price target to $62 from $46
Morgan Stanley raised its price target on Pharvaris to $62.00 per share from $46.00, according to Benzinga ratings actions sourced by TradingView News.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.